MXPA04003679A - Formas de dosificacion, dispositivo y procedimientos de tratamiento. - Google Patents
Formas de dosificacion, dispositivo y procedimientos de tratamiento.Info
- Publication number
- MXPA04003679A MXPA04003679A MXPA04003679A MXPA04003679A MXPA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A MX PA04003679 A MXPA04003679 A MX PA04003679A
- Authority
- MX
- Mexico
- Prior art keywords
- formulation
- active agent
- rumen
- amounts
- predetermined
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0068—Rumen, e.g. rumen bolus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invencion se refiere a un elemento de dosificacion de liberacion controlada adaptado para insertarse en y retenerse en el rumen de un animal rumiante. Dicho elemento comprende: a) una o mas cantidades pequenas y predeterminadas de al menos una primera formulacion que comprende al menos un primer agente activo, estando dicha formulacion adaptada para disolverse en los fluidos del rumen a una velocidad tal que la disolucion de cada una de dichas una o mas cantidades de la primera formulacion proporciona un episodio corto o en pulsos de liberacion de dicho primer agente activo en el rumen; y b) una o mas cantidades predeterminadas de al menos una segunda formulacion adaptada para disolverse a una velocidad controlada en los fluidos del rumen; en el que dichas una o mas cantidades de la primera formulacion se proporcionan en una o mas localizaciones predeterminadas dentro del elemento respecto de dichas una o mas cantidades de la segunda formulacion para una o mas liberaciones retardadas de al menos dicho primer agente activo en dicho rumen a tiempos predeterminados antes, durante y despues, o cualquier combinacion del mismo, de un periodo de tiempo extenso predeterminado definido por dicha segunda formulacion. La invencion tambien se refiere al procedimiento para liberar al menos un primer agente activo al rumen de un animal rumiante de forma retardada a uno o mas tiempos predeterminados tras la administracion a dicho animal de una composicion que contiene dicho agente activo, comprendiendo dicho procedimiento la administracion a dicho animal de un elemento de dosificacion de liberacion controlada segun la invencion. El primer agente activo se aplicara para el tratamiento, profilaxis o ambos de un estado patologico o de infestacion en un animal rumiante, o para alterar el estado fisiologico de un animal rumiante.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPR8390A AUPR839001A0 (en) | 2001-10-19 | 2001-10-19 | Dosage form, device and methods of treatment |
PCT/AU2002/001426 WO2003033031A1 (en) | 2001-10-19 | 2002-10-18 | Dosage form, device and methods of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04003679A true MXPA04003679A (es) | 2004-07-23 |
Family
ID=3832213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04003679A MXPA04003679A (es) | 2001-10-19 | 2002-10-18 | Formas de dosificacion, dispositivo y procedimientos de tratamiento. |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050064032A1 (es) |
EP (1) | EP1448151A4 (es) |
JP (1) | JP2005510485A (es) |
KR (1) | KR20050037410A (es) |
CN (1) | CN1571663A (es) |
AR (1) | AR037116A1 (es) |
AU (5) | AUPR839001A0 (es) |
BR (1) | BR0212975A (es) |
CA (1) | CA2463674A1 (es) |
CR (1) | CR7312A (es) |
EA (1) | EA005778B1 (es) |
EC (1) | ECSP045063A (es) |
HR (1) | HRP20040231A2 (es) |
HU (1) | HUP0401808A3 (es) |
IL (1) | IL160754A0 (es) |
MX (1) | MXPA04003679A (es) |
NO (1) | NO20041941L (es) |
NZ (1) | NZ531672A (es) |
PE (1) | PE20030519A1 (es) |
PL (1) | PL368387A1 (es) |
WO (1) | WO2003033031A1 (es) |
ZA (1) | ZA200403743B (es) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRN20030021A1 (it) | 2003-07-21 | 2005-01-22 | Ascor Chimici Srl | Composizione di materia comprendente particelle contenenti cloruro di colina da somministrare in forma ruminalmente protetta e post-ruminalmente efficace. |
ITMI20041820A1 (it) * | 2004-09-24 | 2004-12-24 | Ascor Chimici Srl | Composizione in micro-pellets a rilascio controllato di sostanze fisiologicamente attive, procedimento di preparazione e relativo impiego nel settore zootecnico. |
US20060246003A1 (en) * | 2004-12-27 | 2006-11-02 | Eisai Co. Ltd. | Composition containing anti-dementia drug |
US20060280789A1 (en) * | 2004-12-27 | 2006-12-14 | Eisai Research Institute | Sustained release formulations |
AU2005320547B2 (en) * | 2004-12-27 | 2009-02-05 | Eisai R & D Management Co., Ltd. | Method for stabilizing anti-dementia drug |
US20090208579A1 (en) * | 2004-12-27 | 2009-08-20 | Eisai R & D Management Co., Ltd. | Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same |
NZ554260A (en) * | 2007-09-30 | 2010-05-28 | Agres Ltd | Selenomethionine andor selenocysteine administration to non-human animals to increase selenium content in protein sources |
WO2010126857A1 (en) * | 2009-04-28 | 2010-11-04 | Wyeth Llc | Parasiticidal combinations of macrocyclic lactones and polyether antibiotics |
AU2014203209B2 (en) * | 2009-07-31 | 2015-11-26 | Boehringer Ingelheim Animal Health USA Inc. | Sustained release capsules |
EP2459116B1 (en) * | 2009-07-31 | 2019-10-09 | Boehringer Ingelheim Animal Health USA Inc. | Sustained release capsules |
US8980896B2 (en) * | 2009-12-17 | 2015-03-17 | Merial, Inc. | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
FR2992219B1 (fr) * | 2012-06-22 | 2014-07-11 | Aditec Lab | Composition pour le traitement de l'hypocalcemie chez les ruminants |
MX2017000041A (es) | 2014-07-03 | 2017-05-01 | Mallinckrodt Llc | Formulaciones de liberacion inmediata disuasivas de abuso que comprenden polisacaridos no celulosicos. |
CA3013321A1 (en) | 2016-02-08 | 2017-08-17 | SpecGx LLC | Glucomannan containing pharmaceutical compositions with extended release and abuse deterrent properties |
WO2018102799A1 (en) * | 2016-12-02 | 2018-06-07 | Clexio Biosciences Ltd. | Gastric residence system |
US11147273B2 (en) * | 2017-06-26 | 2021-10-19 | Boehringer Ingelheim Animal Health USA Inc. | Dual active parasiticidal granule compositions, methods and uses thereof |
CA189877S (en) | 2017-08-25 | 2021-02-18 | Argenta Mfg Limited | Intraruminal device |
EP3849525A4 (en) * | 2018-09-10 | 2022-06-08 | Argenta Innovation Limited | DELAYED RELEASE FORMULATIONS IN DISPENSING DEVICES |
BR112021004523A2 (pt) * | 2018-09-10 | 2021-06-08 | Argenta Innovation Limited | formulações para liberação sustentada em dispositivos de administração |
US11478426B2 (en) | 2018-09-25 | 2022-10-25 | SpecGx LLC | Abuse deterrent immediate release capsule dosage forms |
AU2020328595B2 (en) * | 2019-08-14 | 2023-07-13 | Elanco Tiergesundheit Ag | New wing protector for winged capsule and method of using same |
WO2021158946A1 (en) * | 2020-02-07 | 2021-08-12 | Elanco Animal Health Incorporated | Winged capsule |
WO2021242481A1 (en) * | 2020-05-28 | 2021-12-02 | Boehringer Ingelheim Animal Health USA Inc. | Bi-modal release intra-ruminal capsule device and methods of use thereof |
SI4037666T1 (sl) | 2020-12-08 | 2024-09-30 | Ruminant Biotech Corp Limited | Izboljšave naprav in postopkov za dostavo snovi živalim |
CN113398337A (zh) * | 2021-06-23 | 2021-09-17 | 上海市肺科医院 | 包含抗结核药物缓释植入人工骨载体的脊柱内固定装置 |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU520409B2 (en) * | 1977-05-25 | 1982-01-28 | Commonwealth Scientific And Industrial Research Organisation | Controlled release composition |
GB2077586A (en) * | 1980-06-12 | 1981-12-23 | Standard Telephones Cables Ltd | Sustained-release device |
NZ197543A (en) * | 1980-07-02 | 1984-12-14 | Commw Scient Ind Res Org | Controlled release compositions for inclusion in intraruminal devices |
US4416659A (en) * | 1981-11-09 | 1983-11-22 | Eli Lilly And Company | Sustained release capsule for ruminants |
NZ203203A (en) * | 1982-02-16 | 1985-09-13 | Commw Scient Ind Res Org | Controlled release device:gas diffusion limited |
IE54171B1 (en) * | 1982-06-22 | 1989-07-05 | Univ Glasgow | Device for introducing nutrients and/or therapeutic materials into ruminant animals |
GB8328916D0 (en) * | 1983-10-28 | 1983-11-30 | Castex Prod | Pharmaceutical pellet |
US4777049A (en) * | 1983-12-01 | 1988-10-11 | Alza Corporation | Constant release system with pulsed release |
GR851195B (es) * | 1984-06-02 | 1985-11-25 | Castex Prod | |
US4723958A (en) * | 1986-05-23 | 1988-02-09 | Merck & Co., Inc. | Pulsatile drug delivery system |
US4867980A (en) * | 1986-10-10 | 1989-09-19 | Coopers Animal Health Australia Limited | Heavy density depot |
US5023088A (en) * | 1987-06-25 | 1991-06-11 | Alza Corporation | Multi-unit delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US4874388A (en) * | 1987-06-25 | 1989-10-17 | Alza Corporation | Multi-layer delivery system |
US5110597A (en) * | 1987-06-25 | 1992-05-05 | Alza Corporation | Multi-unit delivery system |
US5938654A (en) * | 1987-06-25 | 1999-08-17 | Alza Corporation | Osmotic device for delayed delivery of agent |
US4957494A (en) * | 1987-06-25 | 1990-09-18 | Alza Corporation | Multi-layer delivery system |
US4915949A (en) * | 1987-07-13 | 1990-04-10 | Alza Corporation | Dispenser with movable matrix comprising a plurality of tiny pills |
GB8829089D0 (en) * | 1988-12-13 | 1989-01-25 | Coopers Animal Health | Intra ruminal device |
DE59000232D1 (de) * | 1989-02-11 | 1992-09-10 | Bayer Ag | Arzneimittel mit kontrollierter wirkstoffabgabe. |
US5110598A (en) * | 1989-06-30 | 1992-05-05 | Smithkline Beecham Corp. | Intermittent release dosage form |
US5126142A (en) * | 1989-07-18 | 1992-06-30 | Alza Corporation | Dispenser comprising ionophore |
US5017381A (en) * | 1990-05-02 | 1991-05-21 | Alza Corporation | Multi-unit pulsatile delivery system |
MX9200339A (es) * | 1991-01-28 | 1992-08-01 | Hoechst Ag | Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes |
US5417682A (en) * | 1991-01-30 | 1995-05-23 | Alza Corporation | Device for administering active agent to biological environment |
AU650113B2 (en) * | 1991-04-05 | 1994-06-09 | Eli Lilly And Company | Sustained release capsule and formulations |
US5240713A (en) * | 1991-09-27 | 1993-08-31 | Alza Corporation | Dual rate agent delivery device |
US5221278A (en) * | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
BR9506533A (pt) * | 1994-01-20 | 1997-09-16 | Pastoral Agric Res Inst Nz Ltd | Dispositivo para administração de materiais benéficos a ruminantes |
AUPM897594A0 (en) * | 1994-10-25 | 1994-11-17 | Daratech Pty Ltd | Controlled release container |
PL205109B1 (pl) * | 1998-11-02 | 2010-03-31 | Elan Pharma Int Ltd | Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie |
US6569857B1 (en) * | 1999-05-03 | 2003-05-27 | Drugtech Corporation | Dietary supplement |
DE19956486A1 (de) * | 1999-11-24 | 2001-06-21 | Lohmann Therapie Syst Lts | Mehrschichtige Zubereitung zur gesteuerten, pulsartigen Abgabe von Wirkstoffen |
EP1251864A4 (en) * | 1999-12-31 | 2006-02-22 | Univ Rutgers | PHARMACEUTICAL FORMULATION COMPRISING A POLYMERIC MIXTURE AND AN ACTIVE COMPOUND FOR TIME-RELEASED RELEASE |
AU2001237424A1 (en) * | 2000-02-28 | 2001-09-12 | Akzo Nobel N.V. | Bodies for the controlled release of active substances |
-
2001
- 2001-10-19 AU AUPR8390A patent/AUPR839001A0/en not_active Abandoned
-
2002
- 2002-10-17 PE PE2002001028A patent/PE20030519A1/es not_active Application Discontinuation
- 2002-10-18 HU HU0401808A patent/HUP0401808A3/hu unknown
- 2002-10-18 KR KR1020047005590A patent/KR20050037410A/ko not_active Application Discontinuation
- 2002-10-18 US US10/490,975 patent/US20050064032A1/en not_active Abandoned
- 2002-10-18 WO PCT/AU2002/001426 patent/WO2003033031A1/en active Application Filing
- 2002-10-18 MX MXPA04003679A patent/MXPA04003679A/es active IP Right Grant
- 2002-10-18 CN CNA028207009A patent/CN1571663A/zh active Pending
- 2002-10-18 EP EP02801251A patent/EP1448151A4/en not_active Withdrawn
- 2002-10-18 AR ARP020103936A patent/AR037116A1/es unknown
- 2002-10-18 CA CA002463674A patent/CA2463674A1/en not_active Abandoned
- 2002-10-18 BR BR0212975-2A patent/BR0212975A/pt not_active IP Right Cessation
- 2002-10-18 NZ NZ531672A patent/NZ531672A/en not_active IP Right Cessation
- 2002-10-18 JP JP2003535833A patent/JP2005510485A/ja active Pending
- 2002-10-18 PL PL02368387A patent/PL368387A1/xx not_active Application Discontinuation
- 2002-10-18 IL IL16075402A patent/IL160754A0/xx unknown
- 2002-10-18 EA EA200400557A patent/EA005778B1/ru not_active IP Right Cessation
- 2002-10-18 AU AU2002332975A patent/AU2002332975C1/en not_active Expired
-
2004
- 2004-03-09 HR HR20040231A patent/HRP20040231A2/hr not_active Application Discontinuation
- 2004-04-15 EC EC2004005063A patent/ECSP045063A/es unknown
- 2004-04-16 CR CR7312A patent/CR7312A/es unknown
- 2004-05-10 NO NO20041941A patent/NO20041941L/no not_active Application Discontinuation
- 2004-05-14 ZA ZA200403743A patent/ZA200403743B/en unknown
- 2004-09-09 AU AU2004210542A patent/AU2004210542C1/en not_active Expired
-
2005
- 2005-10-28 AU AU2005227413A patent/AU2005227413A1/en not_active Abandoned
-
2009
- 2009-12-16 AU AU2009250987A patent/AU2009250987A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AR037116A1 (es) | 2004-10-20 |
US20050064032A1 (en) | 2005-03-24 |
EA200400557A1 (ru) | 2005-02-24 |
HUP0401808A3 (en) | 2005-11-28 |
AU2004210542C1 (en) | 2009-01-08 |
NO20041941L (no) | 2004-05-10 |
CR7312A (es) | 2004-10-27 |
IL160754A0 (en) | 2004-08-31 |
CN1571663A (zh) | 2005-01-26 |
JP2005510485A (ja) | 2005-04-21 |
AU2002332975B2 (en) | 2005-02-03 |
AU2002332975C1 (en) | 2009-01-29 |
PE20030519A1 (es) | 2003-06-13 |
ECSP045063A (es) | 2004-05-28 |
AU2004210542B2 (en) | 2005-07-28 |
ZA200403743B (en) | 2005-05-16 |
AU2009250987A1 (en) | 2010-01-14 |
CA2463674A1 (en) | 2003-04-24 |
AU2004210542B9 (en) | 2005-09-01 |
PL368387A1 (en) | 2005-03-21 |
EP1448151A4 (en) | 2010-01-13 |
AU2005227413A1 (en) | 2005-11-17 |
WO2003033031A1 (en) | 2003-04-24 |
EP1448151A1 (en) | 2004-08-25 |
HRP20040231A2 (en) | 2004-08-31 |
AU2004210542A1 (en) | 2004-09-30 |
KR20050037410A (ko) | 2005-04-21 |
HUP0401808A2 (hu) | 2005-01-28 |
EA005778B1 (ru) | 2005-06-30 |
NZ531672A (en) | 2006-08-31 |
AU2002332975B9 (en) | 2005-03-17 |
BR0212975A (pt) | 2004-10-13 |
AUPR839001A0 (en) | 2001-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA04003679A (es) | Formas de dosificacion, dispositivo y procedimientos de tratamiento. | |
AR040722A1 (es) | Formulaciones y formas de dosificacion para la administracion controlada de topiramato | |
IL174562A0 (en) | Oros push-stick for controlled delivery of active agent | |
NO993520L (no) | Doseringsformer og fremgangsmÕte for Õ bedre erektil dysfunksjon | |
WO2004017941A3 (en) | Transdermal dosage form comprising an active agent and a salt and free-baseform of an antagonist | |
WO2003039436A3 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
CY1107752T1 (el) | Xρηση των εξενδινων και αγωνιστων τους για τη θεραπεια του σακχαρωδους διαβητη της κυησης | |
MXPA02012792A (es) | Composicion y forma de de dosificacion para liberacion gastrica retardada de alendronato y/u otros bis-fosfonatos. | |
HRP20050077B1 (hr) | Postupci i oblici doziranja za kontrolirano oslobađanje paliperidona | |
ATE312595T1 (de) | Formulierung mit mehrfach gepulster wirkstofffreisetzung | |
DK0589893T3 (da) | Anvendelse af et bakteriocin som antimikrobielt middel til fremstilling af et lægemiddel til behandl ing af maveforstyrrelser forbundet med helicobacter pylori | |
WO2002019969A3 (en) | (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents | |
JP2005510485A5 (es) | ||
SE0102276D0 (sv) | Device and method for the administration of a medicament | |
SG146638A1 (en) | Pharmaceutical delivery system | |
HRP20240025T1 (hr) | Liječenje bolesnika s klasičnom fabrijevom bolešću migalastatom | |
HK1038310A1 (en) | Compositions and methods for treating intracellular infections. | |
EP1550443A4 (en) | COMPOSITION AGAINST STRESS-BASED DISEASES | |
MY122477A (en) | Sertraline oral concentrate | |
MXPA03005384A (es) | Composiciones framaceuticas de un inhibidor de bomba de proton revestido no enterico con una combinacion de sal de bicarbonato y sal de carbonato. | |
JPH0649646B2 (ja) | 中枢性鎮痛剤の耐薬性発現抑制剤 | |
Bardin | Implantable contraception | |
RU2010144554A (ru) | Средство для предотвращения и/или лечения сосудистых заболеваний | |
DE60321672D1 (de) | Analgetische orale zusammensetzung mit gesteuerter freisetzung eines opioids | |
DK1129714T3 (da) | Anvendelse af tiludronsyre og dens derivater hos fjerkræ til fremstilling af et lægemiddel, der er beregnet til at forebygge og behandle osteoporose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |